Day: May 9, 2023

NoHo Partners Plc INTERIM REPORT 9 May 2023 at 9.40 EET Correction: NOHO PARTNERS PLC’S INTERIM REPORT 1 JANUARY–31 MARCH 2023: Strong Q1 2023 – the record streak continues NoHo Partners Plc corrects the Interim Report for January 1 – March 31 2023 in English, published on 9 May 2023 at 8.00 EET. In “Events after the reporting period” the turnover referred to an incorrect month. The correct month is April. The Interim Report in Finnish is correct.  The corrected release and Interim Report are available below and attached.    NOHO PARTNERS PLC’S INTERIM REPORT 1 JANUARY–31 MARCH 2023: Strong Q1 2023 – the record streak continues JANUARY–MARCH 2023 IN BRIEFTurnover increased by 56.5% and was MEUR 75.9 (48.5). EBIT increased by 554.6% and was MEUR 5.9 (-1.3). EBIT margin was 7.8% (-2.7%) The result for the period increased by...

The Management Board of AS TALLINNA VESI (registry code 10257326, Ädala 10, 10614 Tallinn) (hereinafter also “the Company”) announces that the Annual General Meeting of Shareholders of the Company will be held on Thursday, 1 June 2023 at 10:00 (UTC+3) in the Blue Auditorium at the Water Treatment Plant at Ülemiste (Address: Järvevana Road 3, Tallinn, Estonia). Registration of the shareholders wishing to participate in the Annual General Meeting in person, will start at 09:00 (UTC+3) on 1 June 2023 at the place of the General Meeting. Registration will end at 09:50 (UTC+3). We kindly ask shareholders and their representatives to arrive as early as possible, considering the time required to register participants. The organizers of the meeting have the right not to take into account late requests for participation and registration in the...

COPENHAGEN, Denmark, May 9, 2023 – Bavarian Nordic A/S (OMX: BAVA) announced today its interim financial results and business progress for the first three months of 2023. Paul Chaplin, President & Chief Executive Officer of Bavarian Nordic said: “We are pleased to report strong results from the first quarter, driven by the continued deliveries of mpox vaccines to countries worldwide combined with a strong performance in our travel vaccine business. The major highlight for the quarter was the announcement of the acquisition of the travel vaccine portfolio from Emergent BioSolutions. This transaction will expand our portfolio of both marketed and pipeline products, broaden our R&D, manufacturing and commercial capabilities, and not least strengthens our workforce with nearly 300 employees whom we are pleased to welcome to Bavarian...

EEZY PLC — INTERIM REPORT   — 9 MAY 2023 AT 8:00 Eezy Plc‘s Interim Report 1–3/2023: Profitability improved in first quarter January–March 2023Revenue was EUR 52.8 million (EUR 50.9 million in January–March 2022). Revenue grew by 4%. EBITDA was EUR 3.4 million (2.5). EBIT was EUR 1.3 million (0.5) and was 2.5% of revenue (1.0%). Earnings per share was EUR 0.02 (0.00).Outlook for 2023 Eezy expects revenue to be approx. EUR 250 million and EBIT-% to grow in 2023. Key figures (IFRS)EUR million, unlessotherwise specified 1–3/2023 1–3/2022 1–12/2022Revenue         52.8 50.9 247.6EBITDA 3.4 2.5 18.2EBITDA, % 6.5% 4.9% 7.4%EBIT 1.3 0.5 10.0EBIT, % 2.5% 1.0% 4.0%EPS, undiluted, EUR 0.02 0.00 0.29EPS, diluted, EUR 0.02 0.00 0.28Net debt / EBITDA 3.0 x 2.8 x 2.9 xChain-wide revenue 73.8 77.0 351.6Interim...

Revenue up 7%, full-year outlook maintained (unaudited) ALK’s overall results in Q1 2023 were largely as expected, with 7% organic revenue growth in local currencies and increased operating profit with an EBIT margin of 18%. Combined SCIT and SLIT-drops sales exceeded expectations, while tablet sales were around DKK 35 million lower than planned on slower growth in new patient initiations. The full-year revenue and earnings outlook remains unchanged. Q1 2023 financial highlights Comparative figures for Q1 2022 are shown in brackets. Revenue growth rates are stated in local currencies, unless otherwise indicatedRevenue increased 7% to DKK 1,234 million (1,155) on high, single-digit growth from all sales regions. The one-year, mandatory rebate increase of 5 percentage points in Germany lowered revenue growth by approximately 1 percentage...